Login / Signup

Changes in psychotropic polypharmacy and high-potency prescription following policy change: Findings from a large scale Japanese claims database.

Masahiro TakeshimaMinori EnomotoMasaya OgasawaraMizuki KudoYu ItohKazuhisa YoshizawaDai FujiwaraYoshikazu TakaesuKazuo Mishima
Published in: Psychiatry and clinical neurosciences (2022)
Keyphrases
  • adverse drug
  • public health
  • healthcare
  • health insurance
  • mental health